Home

Alantra advises Alpha Bank on the sale of Portfolio Mercury, c.EUR 2bn non-performing unsecured consumer, small business and personal insolvency loan portfolio in Greece

29 November

Athens, November 29, 2018 – Alantra portfolio advisory team (“Alantra CPA”) is pleased to announce its role as advisor to Alpha Bank, one of Greece’s four systemic banks, on the signing of a transaction whereby Hoist Finance has entered into an agreement to acquire a Greek unsecured non-performing loan portfolio with a total outstanding balance […]

Alantra PE wins Private Equity Exchange’s Best Spanish LBO Fund Award

22 November

Alantra’s Private Equity division (“Alantra PE”) has won the Best Spanish LBO Fund Award during the 9th edition of the Private Equity Exchange Awards, which were celebrated in Paris on November 21st. The jury was made up of more than 80 high-profile experts, including Limited Partners and Asset Managers, from across the world. This award […]

ICIS: M&A streak is all set to continue

20 November

Dr. Bernd Schneider, head of Chemicals & Polymers at Alantra explains the good health of the chemical sector in the M&A market at the ICIS Chemical Business Magazine. Click here to read the full article.

Alantra advises Visible Body on Strategic Investment by Capitala Group and Lineage Capital

18 November

BOSTON, November 19, 2018 –ALANTRA, a leading global middle-market investment bank and asset management firm, is pleased to announce that its client, Visible Body, creator of the world’s best-selling human anatomy app, has entered into a strategic partnership with Capitala Group and Lineage Capital. The deal closed on November 7, 2018 and the transaction value […]

Alantra advised Quadriga Capital on the sale of Alicona Imaging to US-based Bruker Corporation

14 November

Frankfurt, November 14, 2018 – Alantra, a global investment banking and asset management company focused on the mid-market segment has advised funds advised by Quadriga Capital Private Equity Fund IV LP (“Quadriga Capital”) on the sale of Alicona Imaging GmbH (“Alicona”), a provider of high-resolution optical 3D metrology solutions, to Bruker Corporation (“Bruker”) for an […]

Alantra advises Branford Castle on the Sale of Canada Metal (Pacific) Ltd

12 November

BOSTON, November 13, 2018 –ALANTRA, a leading global middle-market investment bank and asset management firm, is pleased to announce that its client Branford Castle, Inc. (“Branford Castle”), a New York-based investor and affiliate of private equity manager Branford Castle Partners, LP, has sold its portfolio company Canada Metal (Pacific) Limited (“CMP” or the “Company”) to […]

Alantra advises Quadriga Capital on the sale of DOREA to Groupe Maisons de Famille

7 November

Berlin/Frankfurt/Paris, 7 November 2018 – Alantra, a global investment banking and asset management company focused on the mid-market segment has advised Dorea Beteiligung S.à r.l. on the sale of DOREA Holding GmbH (“DOREA”), a leading German nursing care operator, owned by funds advised by Quadriga Eigenkapitalberatung GmbH (“Quadriga”), to Groupe Maisons de Famille (“MdF”) for […]

Alantra advised Bencis Capital Partners / BRB International on the acquisition of a strategic majority interest in CSL Silicones Inc.

30 October

Amsterdam, October 30, 2018 – Alantra, a global investment banking and asset management company focused on the mid-market segment, has advised Bencis Capital Partners (“Bencis”) and BRB International B.V. (“BRB”) on the strategic majority interest in CSL Silicones Inc. (“CSL”). Founded 34 years ago and located in Guelph, ON, Canada, CSL has grown leading positions […]

Alantra advises Gilde Buyout Partners on the sale of Riri Group to Chequers Capital

30 October

• Riri is a specialized provider of zippers and buttons for luxury fashion, a dynamically growing market • This is the second transaction Alantra has advised in involving Riri, following the acquisition of the Company by Gilde Buyout Partners in 2014. It also represents the third deal executed for Gilde in the last five years. […]

Mark’ennovy Completes Growth Funding

26 October

Accelerating global development for the leader in custom fit extended range contact lenses  October 23rd, 2018 – Mark’ennovy Personalized Care, European-based provider of precision contact lenses, is pleased to announce the completion of a significant debt and equity funding package. Bond Capital Partners, a London based, independent investor and advisor to small and medium-sized businesses […]